Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy
Background: Diabetic retinopathy (DR) is a major cause of blindness globally.Sodium Glucose Cotransporter-2 (SGLT2) inhibitors have been demonstrated to exert cardiorenal protection in patients with diabetes.However, their potential beneficial effect on DR is less well studied.The aim of the present study was to determine the effects of the SGLT2 i